Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7511616 | International Journal of Drug Policy | 2018 | 9 Pages |
Abstract
Washington's state-legal cannabis market is diverse and rapidly evolving in terms of pricing, products, and organization. Post-legalization, researchers and policy makers may need to think in terms of a family of cannabis products, akin to how we think of new psychoactive substances and amphetamine-type stimulants, not a single drug “cannabis.”
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Jonathan P. Caulkins, Yilun Bao, Steve Davenport, Imane Fahli, Yutian Guo, Krista Kinnard, Mary Najewicz, Lauren Renaud, Beau Kilmer,